SCHEMBL14954367

SCHEMBL14954367

CC1=C(C)C(C)(C)C([Ru])=C1C.[H-].[H-]

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CTSD P07339 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL198310 0.97 CTSD (0.35) CTSD
Bromide SCHEMBL14953771 0.94 CTSD (0.33) CTSD
Hydrochloric Acid SCHEMBL1450192 0.94 CTSD (0.33) CTSD
Iodide SCHEMBL14954347 0.94 CTSD (0.33) CTSD
Fluoride SCHEMBL14954494 0.94 CTSD (0.33) CTSD
Water SCHEMBL6129328 0.94 CTSD (0.33) CTSD
Hydrochloric Acid SCHEMBL14954076 0.94 CTSD (0.33) CTSD
SCHEMBL18605788 0.75 CYP3A4 (0.44)
SCHEMBL2230540 0.73 CTSD (0.43) CTSD
SCHEMBL14954188 0.71 CTSD (0.33) CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722912-B2 Metal complex compound and process for producing amides utilizing the metal complex compound NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) 2014-05-13 US disclosed
US-20130131366-A1 Metal Complex Compound and Process for Producing Amides Utilizing the Metal Complex Compound NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) 2013-05-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131366-A1 Metal Complex Compound and Process for Producing Amides Utilizing the Metal Complex Compound AP2M1, ASH2L, AP2A1 CTSD 4711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.